“Significant” FDA publications
This article was originally published in The Tan Sheet
The "Index of Significant OTC Drug Federal Register Publications: 2000-2009" is now available through FDA's Center for Drug Evaluation & Research 1website. The index lists over 95 announcements chronologically, such as proposed monograph amendments, industry guidances and calls for data and comments...
You may also be interested in...
A trio of newly finalized guidance documents from the US agency dated 25 September explain how the Accreditation Scheme for Conformity Assessment pilot will work, and what biocompatibility and safety standards will apply.
Approval of Alaway Preservative Free (ketotifen fumarate, 0.035) comes 15 months after FDA submitted a complete response letter to Bausch and the active ingredient developer, Eton Pharmaceuticals.
Unfounded expectation some firms have for FDA to protect their investments in preparing successful NDI notifications is part of industry’s overall interest in increased regulation of the market, says Steven Tave, Office of Dietary Supplement Programs director.